CAP-XX Limited Overview
CAP-XX is a micro-cap Australian designer and manufacturer of thin, prismatic electric double-layer capacitors (supercapacitors). The products deliver short, high-current power bursts from very small, flat packages, down to 0.4 mm thick. Its core competence is high power density in space-constrained electronics: IoT nodes, wearables, professional headsets, smart meters, medical sensors and industrial devices. It is extending into modules for industrial back-up, grid stabilisation and data-centre applications.
After two decades as a largely IP-licensing story (Murata, AVX, TDK, Cornell Dubilier), CAP-XX bought Murata's supercapacitor production lines in 2019 and moved them to Sydney. It is now an owner-operator manufacturer. A costly, failed patent suit against Tesla-owned Maxwell Technologies (2023) ended the licensing-led era.
Under CEO Lars Stegmann (from 2023) and Chairman Dr Graham Cooley (from March 2025), the strategy is distribution-led volume growth. This runs through SCHURTER, Würth Elektronik, Farnell, RS, Waldom and DigiKey, alongside capacity upgrades. CAP-XX remains loss-making and dependent on equity raises and Australian R&D tax refunds.
What the company does. CAP-XX designs and manufactures supercapacitors and related energy-management systems. Its description of itself in the FY25 results and H1 FY26 interims is consistent: a designer and manufacturer of thin, flat supercapacitors and energy management systems.
Primary use: portable and small-scale electronic devices.
Growing use: larger applications such as automotive and renewable energy.
Claimed differentiator: very high power density and high energy storage capacity in a space-efficient prismatic package (FY25 results; H1 FY26 interims; Notes to Editors).
Business model. CAP-XX earns almost all its revenue from the sale of physical goods, recognised at a point in time.
FY25 split: sale of goods A$4.70m and "other services" A$0.235m (FY25 Note 5).
FY24 split: all A$4.59m was sale of goods.
Licensing: historically material, but no royalty or licence revenue appears as a separate line in FY24–FY25. As of H1 FY22, management noted no royalty or licensing revenue in that half, versus A$0.4m in H1 FY21.
The model has therefore moved from licensing-heavy to product-heavy.
Indicative revenue model mix (FY25):
Source: FY25 audited results, Note 5.
Non-revenue income. The P&L depends heavily on Australia's R&D Tax Incentive, booked as "other income":
-
FY25: A$1.75m
-
FY24: A$1.95m
In FY25 this exceeded gross profit (A$1.47m). The A$1.75m FY25 refund was received in cash in H1 FY26 (H1 FY26 cash flow; RNS 19 Dec 2025).
Value-chain position. CAP-XX sits in the passive-components tier:
-
It buys carbon/electrode materials, electrolytes, separators and packaging.
-
It manufactures cells at Seven Hills (Sydney).
-
It uses contract or partner capacity in Malaysia and China. The CEO's FY25 statement describes a diversified production base across Malaysia, China and Australia.
It sells through three routes:
-
Global broadline and specialist distributors: Farnell (Avnet), RS Group, Waldom, DigiKey, JM elektronik, and from 2026 Würth Elektronik.
-
A white-label partner, SCHURTER AG, which sells CAP-XX-made supercaps under its own brand.
-
Direct design-wins with OEMs.
Customer types. CAP-XX sells to OEMs and ODMs in industrial electronics, IoT/wireless sensing, smart metering, professional headsets/audio, medical devices, wearables and solid-state storage. Most customers are reached through distribution. Disclosed design-wins include:
-
A "multinational conglomerate" (RNS 13 May 2025)
-
A "global semiconductor manufacturer" (RNS 5 Aug 2025)
-
A next-generation headphone platform with a major Asian manufacturer (FY25 Chairman's Statement)
-
A South African smart-metering client (Sharecast headline, 2024)
End-markets served (per company statements):
-
Professional headsets and industrial applications (cited as current traction)
-
Emerging defence, aviation and satellite opportunities (FY25 CEO statement)
-
IoT, industrial and mobility (FY25 Review of Operations)
-
Industrial and medical electronics via SCHURTER
-
Grid stabilisation and data centres for the developing Module range (Placing RNS, 30 Jul 2026)
Independent characterisation. CAP-XX is a sub-scale, single-technology component maker with a credible niche. Thin prismatic supercaps are a small sub-segment of a market dominated by cylindrical and module formats. Its revenue base (~US$3.4m) is tiny relative to the capital intensity of cell manufacturing. That is why gross margin collapsed from the low-40s% (FY21–FY23) to ~30% (FY24–FY25) as the business moved from licence-assisted revenue to owner-operated manufacturing with under-utilised fixed cost.
The investment case turns on three questions:
-
Can distribution partners generate enough design-in volume to fill the ex-Murata lines?
-
Can capacity upgrades restore margins?
-
Can the company reach cash-flow breakeven before shareholder dilution becomes prohibitive?
The original target was breakeven in calendar 2026 (Trading Update, 7 May 2024). That timetable is now very unlikely given FY26 trading.
Strategy
Stated corporate strategy (themes paraphrased from FY25 Annual Report, H1 FY26 interims and 2026 placing RNS)
-
Path to profitability and positive operating cash flow. Achieved through higher volumes, richer product mix, efficiency gains and accelerating design-wins (FY25 Outlook). The H1 FY26 CEO statement says the entire operational focus is on becoming cash-flow positive.
-
Distribution-led commercial scaling. Build a global distribution network (Farnell/Avnet, RS, Waldom, DigiKey, JM elektronik, Würth Elektronik) to convert design-ins into a more predictable, recurring sales base (Placing RNS 2026).
-
Strategic white-label partnership with SCHURTER. Co-branded and white-label supercaps with joint technology development (TCA, Mar 2025).
-
Manufacturing scale-up and repatriation. Upgrade the DMF/DMT line, expand DMH to full production by FY27, build a clean coating room, and move Nation Gate production to Australia (Placing RNS 2026).
-
Product-range broadening. SMT reflow-capable supercaps, 3V prismatics, ultra-thin DMH, and modules for grid and data-centre applications.
-
Operational excellence and governance. Datapel WMS, Pipeliner CRM, MYOB integration, Power BI reporting, a new auditor and tighter financial controls (FY25; H1 FY26).
-
Target-market focus. Professional headsets and industrial today; defence, aviation and satellite emerging (FY25 CEO statement).
Strategic initiatives register (last 24 months)
| Date | Initiative | Type | Detail / target | Source |
|---|---|---|---|---|
| May 2024 | Cost-reduction programme | Cost | >US$0.5m annualised opex savings. Breakeven target: calendar 2026. | Trading Update, 7 May 2024 |
| Jul 2024 | SCHURTER MoU | Partnership | Joint technology and co-branded product development | RNS, 15 Jan 2025 |
| Nov 2024 | electronica showcase | Go-to-market | SCHURTER range of three products, 40+ variants | SCHURTER, Nov 2024 |
| Jan 2025 | JM elektronik distribution | Channel | Poland: smart metering, medical | RNS, 17 Jan 2025 |
| Mar 2025 | Waldom master distribution | Channel | Master distributor | RNS, 7 Mar 2025 |
| Mar 2025 | SCHURTER Technology Cooperation Agreement | Partnership | Synergies across R&D, manufacturing and sales | RNS, 12 Mar 2025 |
| Mar 2025 | Premier Farnell global distribution | Channel | Global | RNS, 18 Mar 2025 |
| Mar 2025 | Board restructuring and option grants | Governance / incentives | Cooley becomes Chair | RNS, 19/26 Mar 2025 |
| May 2025 | Website relaunch | Marketing | — | RNS-R, 30 May 2025 |
| Jun 2025 | RS Group global distribution | Channel | EMEA and North America reach | RNS, 30 Jun 2025 |
| FY25 – Sep 2025 | Datapel WMS / Pipeliner CRM / MYOB / Power BI integration | Operations / digital | Real-time reporting; inventory and cost-allocation accuracy | FY25 results; RNS, 16 Sep 2025 |
| Jul 2026 | Production-line investment programme | Capex | DMF/DMT upgrade; DMH capacity to full production by FY27; clean coating room | Placing RNS, 30 Jul 2026 |
| Jul 2026 | Nation Gate line repatriation | Footprint | Transition customers to existing lines; manufacture in Australia | Placing RNS, 30 Jul 2026 |
| 2,026 | Würth Elektronik partnership | Channel / partnership | Broader set of global distribution agreements | Placing RNS, 30 Jul 2026 |
| 2,026 | Module range development | New business | Grid stabilisation, data centres | Placing RNS, 30 Jul 2026 |
ESG/sustainability commitments: None formally announced in the materials reviewed.
Medium-term targets and guidance
| Target | Status | Source |
|---|---|---|
| Breakeven in calendar 2026 | Set May 2024, conditional on billings growth continuing. Not reiterated in 2026 materials. H1 FY26 EBITDA loss of A$1.13m makes calendar-2026 breakeven highly unlikely. | Trading Update, 7 May 2024; H1 FY26 interims |
| Cash-flow positive | Stated as the overriding operational goal; no date given | H1 FY26 interims |
| DMH full production | By FY27 | Placing RNS, 30 Jul 2026 |
| Revenue growth acceleration | Board expects to accelerate revenue growth over the coming financial year (FY27) on new capacity and a broader range; no numeric guidance | Placing RNS, 30 Jul 2026 |
Products & Services
Because CAP-XX is single-segment, products are grouped by product family. Pricing is not publicly disclosed; products are sold through distributor list prices and OEM quotes. At the Murata transfer, CAP-XX stated it planned to keep Murata's existing pricing on DMF, DMT and DMH (EEPower, Dec 2019).
Ex-Murata thin supercapacitor families (manufactured at Seven Hills since 2020)
| Product | Description & key capabilities | Target customers / applications | Status | Source |
|---|---|---|---|---|
| DMF series | General-purpose, very high power, long life. Very low ESR and wider operating voltage range. PCB-mountable. | Wireless comms bursts, displays, haptics, GPS acquisition, industrial IoT | In production. 2026 placing funds a line upgrade on what the company calls a strongly performing line. | EEPower Dec 2019; Placing RNS 30 Jul 2026 |
| DMT series | High-power, ultra-long-life, high-temperature. Thin enough for PCB assembly. | Solid-state drives (power-loss protection), automotive, harsh environments | In production. Shares the DMF/DMT line being upgraded. | EEPower Dec 2019; Placing RNS 2026 |
| DMH series | Ultra-thin 0.4 mm supercapacitor | Smartphones, smart cards, wearables, medical sensors, 3V coin-cell replacement, very thin IoT | Murata launched it in Jan 2017. CAP-XX is expanding capacity, targeting full production by FY27. | Sharecast Jan 2017; EEPower; Placing RNS 2026 |
Legacy CAP-XX prismatic supercapacitors
| Product | Description | Status | Source |
|---|---|---|---|
| Thin prismatic single and dual-cell supercapacitors (historic GS/GW/HS/HW-type ranges) | High-power-density flat packages. CAP-XX's original product line, made historically by contract manufacturers in Penang (Polar Twin Advance, Nationgate). | The 2026 RNS says the "Nation Gate product line" will be relocated and its customers moved onto existing lines, with manufacturing repatriated to Australia. | Annual Report 2009; Placing RNS 2026 |
| DMV | 3V, 750 mF, 21 × 14 × 2.2 mm supercapacitor | Listed in secondary sources | Wikipedia mirror |
New and developing platforms
| Product | Description | Development stage | Source |
|---|---|---|---|
| SMT (surface-mount) supercapacitors | Capable of automated reflow-oven assembly. This removes a key barrier to high-volume adoption (manual or post-reflow placement). | In development. Board is reviewing commercial applications, demand and revenue potential. Revenue contribution was originally guided for 2026. | FY25 Review of Operations; Placing RNS 2026; Trading Update 7 May 2024 |
| 3V prismatic capacitors | Single-cell 3V devices to simplify system integration | Development, per FY25 | FY25 Review of Operations |
| Module range | Supercapacitor modules for industrial uses, including grid stabilisation and data centres. Positioned as a more reliable, service-free alternative to battery systems. | In development | Placing RNS, 30 Jul 2026 |
| Clean coating room (enabling capex) | New electrode-coating cleanroom applicable across all product lines | Funded by the 2026 raise | Placing RNS, 30 Jul 2026 |
Energy-management systems / automotive
| Product | Description | Status | Source |
|---|---|---|---|
| truckStart | Supercapacitor engine-start module for trucks and cars. Reduces lead-acid battery wear, improves cold-cranking and acts as a regenerative-braking energy store. | Developed in 2015. Current commercial volumes not disclosed. | Company page; LSE news |
| High-energy cells and modules for automotive/large-scale use | New line developed and tested in the mid-2010s | Historic; commercial status not disclosed | Company corporate-development page |
Partner-branded and licensed products
| Offering | Description | Status | Source |
|---|---|---|---|
| SCHURTER-branded prismatic supercaps (white label) | Three products in more than 40 variants. As thin as 0.4 mm; SCHURTER markets them as the world's thinnest high-power-density supercaps. | Launched at electronica in Nov 2024. First shipment Jan 2025. As of Jul 2026: commercial and engineering contracts signed, white-label products launched, pipeline building. | SCHURTER press release, Nov 2024; RNS 15 Jan 2025; Placing RNS 2026 |
| Patent licences (Murata 2008, AVX 2016, TDK 2018, Cornell Dubilier 2019) | Manufacturing and patent licences | Historic. Current royalty income is not separately disclosed (see Section 2). Royalties in FY23 came mainly from AVX, with court proceedings over amounts owed. | Company pages; FY23 results summary |
Services
| Offering | FY2025 revenue | Source |
|---|---|---|
| Engineering / other services (recognised at a point in time) | A$0.235m | FY25 Note 5 |
Financial Narrative
Data provenance:
-
FY2024–FY2025 are from audited FY25 statements (FY24 restated).
-
FY2021–FY2023 P&L lines are from aggregator StockAnalysis, cross-checked with Investing.com and company commentary where possible.
-
FY2026 figures are unaudited headline numbers from the 30 Jul 2026 placing RNS. Only revenue is available for the full year.
"n/a" means not available in the sources reviewed; it is not an estimate.
Income statement
Notes:
FY26 revenue (A$5.24m, unaudited): The company describes this as an 11% increase on the prior year. Arithmetically, A$5.24m against audited FY25 revenue of A$4.94m is only +6.1%. The base used for the 11% claim is not explained in the RNS. This discrepancy should be resolved when the FY26 audited accounts are published.
FY22 EBITDA (−A$2.8m): As cited in the FY23 trading update (Alliance News, Aug 2023).
FY23 EBITDA (−A$1.3m): This is company "adjusted" EBITDA, excluding certain items (CEO-change costs flagged), so it is not comparable with FY24–FY25 statutory-basis EBITDA.
FY22–FY23 net losses: From Investing.com.
FY24 EBITDA: Restated (−A$5.11m) and includes ~A$2.26m legal expenses (FY25 Note 7).
EPS: In Australian cents (FY25 Note 33; Investing.com for FY22–FY23).
Margins (%)
Revenue CAGR:
-
FY2021–FY2025 (4 years): +4.8% p.a.
-
FY2021–FY2026 (5 years, FY26 unaudited): +5.0% p.a.
Both are analyst calculations from the table above.
Half-year detail (A$, unaudited, H1 FY26 interims):
Implied H2 revenue (analyst calculation): H2 FY25 = A$2.52m; H2 FY26 = A$2.61m (+3.6% YoY). Despite a 31% jump in H1 bookings and a A$2.8m backlog at 31 Dec 2025, H2 FY26 revenue was roughly flat on H1 FY26. That suggests capacity constraints, which is consistent with the stated rationale for the 2026 raise.
Balance sheet
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment / Revenue line
| Segment / Revenue line | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Sale of goods (AUD Mn) | — | 4.59 | 4.70 |
Other services (AUD Mn) | — | 0.00 | 0.24 |
Total revenue (AUD Mn) | 3.63 | 4.59 | 4.94 |
Total revenue YoY growth (%) | -34.7 | 26.5 | 7.5 |
Results by Segment and Segment Margins & Growth (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Gross profit (AUD Mn) | 1.57 | 1.38 | 1.47 |
Gross margin (%) | 43.3 | 30.0 | 29.7 |
Loss before tax (AUD Mn) | -5.56 | -6.14 | -3.93 |
Pre-tax margin (%) | -153.2 | -133.8 | -79.5 |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
Revenue (AUD Mn) | 4.10 | 5.56 | 3.63 | 4.59 | 4.94 | 5.24 |
Revenue growth (%) | 14.3 | 35.6 | -34.7 | 26.5 | 7.5 | 6.1 |
Cost of sales (AUD Mn) | 2.34 | 3.03 | 2.06 | 3.21 | 3.47 | — |
Gross profit (AUD Mn) | 1.76 | 2.52 | 1.57 | 1.38 | 1.47 | — |
Other income incl. R&D tax incentive (AUD Mn) | — | — | — | 1.95 | 2.14 | — |
Research expenses (AUD Mn) | 1.48 | 1.57 | 1.38 | 1.26 | 1.28 | — |
EBITDA, company-defined (AUD Mn) | — | -2.80 | -1.30 | -5.11 | -3.04 | — |
Loss before tax (AUD Mn) | — | -4.94 | -5.56 | -6.14 | -3.93 | — |
Net loss after tax (AUD Mn) | — | -4.94 | -5.56 | -6.14 | -3.93 | — |
Basic & diluted EPS (A cents) | — | -1.00 | -1.10 | -0.55 | -0.08 | — |
Dividends per share (A cents) | 0 | 0 | 0 | 0 | 0 | 0 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 42.9 | 45.4 | 43.3 | 30.0 | 29.7 |
EBITDA margin, company-defined (%) | — | -50.4 | -35.8 | -111.3 | -61.6 |
Pre-tax margin (%) | — | -88.8 | -153.2 | -133.8 | -79.5 |
Net margin (%) | — | -88.8 | -153.2 | -133.8 | -79.5 |
Income Statement and Margin Analysis (%) (Half-Yearly)
| Metric | H1 FY2025 | H1 FY2026 |
|---|---|---|
Revenue (AUD Mn) | 2.42 | 2.63 |
Gross profit (AUD Mn) | 0.85 | 0.77 |
Gross margin (%) | 35.0 | 29.1 |
Other income (AUD Mn) | 1.11 | 0.94 |
Process & engineering (AUD Mn) | 1.14 | 0.65 |
R&D expenses (AUD Mn) | 0.60 | 0.66 |
Selling & marketing (AUD Mn) | 0.30 | 0.40 |
G&A (AUD Mn) | 1.49 | 1.42 |
EBITDA (AUD Mn) | -1.21 | -1.13 |
Net loss (AUD Mn) | -1.69 | -1.53 |
EPS (A cents) | -0.051 | -0.027 |
Balance Sheet and Share Count (m)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Total assets (AUD Mn) | — | 13.06 | 10.21 | 11.05 |
Cash & equivalents (AUD Mn) | — | 2.64 | 1.76 | 3.96 |
Short-term borrowings (AUD Mn) | — | 1.10 | 0.77 | 0.00 |
Long-term borrowings (AUD Mn) | — | 0.00 | 0.00 | 0.00 |
Lease liabilities, total (AUD Mn) | — | — | 2.01 | 1.74 |
Net debt incl. leases (AUD Mn) | — | — | 1.02 | -2.22 |
Net debt excl. leases (AUD Mn) | — | -1.54 | -0.99 | -3.96 |
Total equity (AUD Mn) | 6.84 | 6.53 | 4.45 | 6.70 |
Goodwill & intangibles (AUD Mn) | — | — | 0.00 | 0.15 |
Working capital, CA − CL (AUD Mn) | — | — | 2.97 | 5.28 |
Shares in issue (m) | — | — | 2,908.2 | 5,775.6 |
Cash Flow and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | — | — | — | -4.04 | -2.35 |
of which R&D tax incentive received (AUD Mn) | — | — | — | 2.08 | 1.95 |
Capex incl. intangibles (AUD Mn) | — | — | — | -0.02 | -0.19 |
Free cash flow (AUD Mn) | — | — | — | -4.06 | -2.54 |
FCF margin (%) | — | — | — | -88.4 | -51.4 |
Net equity raised (AUD Mn) | — | — | — | 3.97 | 5.83 |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Cash Flow History
| Date | Cash | Source |
|---|---|---|
30 Jun 2025 | A$3.96m | FY25 results |
31 Oct 2025 | A$1.5m (after A$0.85m non-recurring costs and creditor catch-up) | FY25 results |
31 Dec 2025 | A$2.92m (post refund) | H1 FY26 interims |
Jul–Sep 2026 | ~£2.3m gross equity raised (≈ A$4.6m), mostly earmarked for production-line capex | Placing RNS; Perivan |
Returns & Leverage Ratios (%)
| Ratio | FY2024 | FY2025 |
|---|---|---|
ROE (%) | -111.8 | -70.5 |
ROA (%) | -52.8 | -37.0 |
ROIC (%)
| ROIC (%) | n/m | n/m |
|---|---|---|
Current ratio (x) | 1.95 | 3.39 |
Debt/equity incl. leases (x) | 0.62 | 0.26 |
Net debt/EBITDA (x)
| Net debt/EBITDA (x) | n/m | n/m |
|---|---|---|
Interest coverage, EBITDA/interest (x) | n/m | n/m |
Asset turnover (x) | 0.43 | 0.46 |
Days sales outstanding | 55 | 51 |
Days inventory outstanding | 191 | 104 |
Days payables outstanding | 173 | 99 |
Cash conversion cycle (days) | 72 | 56 |
Revenue by Region
| Region | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Total revenue (AUD Mn) | 3.63 | 4.59 | 4.94 |
Share Price History
| Date | Price (p) | Context | Source |
|---|---|---|---|
Dec 2019 | 3.06 | After Murata deal / placing announcement (−16% on the day) | Sharecast |
Feb 2021 | 10.45 | H1 FY21 results | Alliance News |
2 Aug 2023 | 1.50 | FY23 revenue warning (−14%) | Alliance News |
18 Dec 2023 | 0.77 | Maxwell verdict (−55%) | Alliance News |
19 Feb 2024 | 0.62 | Appeal dropped (−8.7%) | Sharecast |
17 Feb 2025 | 0.12 | H1 FY25; down 80% over 12 months | Alliance News |
7 Nov 2025 | 0.27–0.28 | FY25 results (−11% to −14%) | Sharecast; Alliance News |
8 Jan 2026 | 0.22–0.24 | Bid/offer | Fidelity |
29 Jul 2026 | 0.22 | Close before placing | Placing RNS |
30 Jul 2026 | 0.15 | Placing price | Placing RNS |
~9 Oct 2026 | 0.1225 | Latest delayed quote | London South East |
Approx. Change by Horizon
| Horizon | Approx. change | Basis |
|---|---|---|
1-year | −55% to −60% | ~0.28–0.32p in Oct–Nov 2025 → 0.1225p |
3-year | ~−92% | ~1.5p (Aug 2023) → 0.1225p |
5-year | ~−99% | ~10p (2021) → 0.1225p |
Capital Markets
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Shares in issue at period end, m (FY26 = 30 Sep 2026) | 2,908.2 | 5,775.6 | 7,424.0 |
Weighted average shares, m | 1,118.1 | 4,774.0 | — |
Valuation Multiples
| Multiple | CAP-XX | Basis | Peer comparison |
|---|---|---|---|
Market cap | £9.09m ≈ A$18.4m | 0.1225p × 7.424bn shares | — |
P/E | n/m | Loss-making | n/m |
EV/EBITDA | n/m | Negative EBITDA | n/m |
Market cap / FY26 sales | ~3.5x | A$18.4m / A$5.24m (unaudited) | Diversified passive-component peers typically trade at well under these levels on sales; no peer multiples verified this session |
EV / FY26 sales | ~2.6–3.2x | Market cap less estimated post-raise cash (range reflects undisclosed 30 Jun 2026 cash plus ~£2.3m gross raised) | — |
P/B | ~3.5x pre-raise; lower post-raise | £9.09m vs 31 Dec 2025 net assets A$5.30m (≈£2.6m); post-raise equity not yet reported | — |
Capital Markets — Credit ratings
| Item | Status |
|---|---|
Credit ratings (Moody's / S&P / Fitch) | Not rated |
Financial debt | Nil at 30 Jun 2025 and 31 Dec 2025 |
Lease liabilities (31 Dec 2025) | A$0.45m current; A$1.15m non-current (Seven Hills lease) |
Historic borrowings | R&D-advance-style facilities secured against tax refunds (FY24 borrowings A$0.77m; interest on R&D advance A$0.08m in FY25) |
Share Price & Returns
| Date | Amount | Price | Notes | Source |
|---|---|---|---|---|
Jan 2017 | £2.43m | — | Development projects | Sharecast |
Dec 2019 | ~£2.75m | ~3p area | Murata lines | Sharecast |
| 2023 | — | Discounted | Alongside CEO change | Wikipedia |
FY24 | A$3.97m net | — | Plus warrants issued | FY25 cash flow / SOCE |
H2 CY2024 | £2.75m (A$5.83m net in FY25 incl. other issues) | — | Oversubscribed; Cooley to 9.98% | Sharecast; FY25 |
Jul–Sep 2026 | ~£2.3m gross | 0.15p | Two tranches plus retail offer; director fee conversion | Placing RNS; Perivan |
Analyst Conclusions
Management guidance
Numeric guidance: None for FY27.
Qualitative guidance: The board expects expanded capacity and a broader product range to accelerate revenue growth over the coming financial year (Placing RNS, 30 Jul 2026).
DMH: Full production targeted by FY27.
Cash flow: Becoming cash-flow positive remains the overriding goal (H1 FY26 interims).
Breakeven: The calendar-2026 breakeven target (May 2024) has not been reiterated.
Consensus expectations
No sell-side consensus is available.
Bull case
-
Order momentum is real and capacity is the bottleneck. FY26 bookings rose 34.9% to A$6.71m against revenue of A$5.24m, a book-to-bill of about 1.28. Backlog is A$3.42m. If the 2026 capex unlocks DMH and DMF/DMT output, FY27 revenue could step up materially without matching opex growth.
-
Channel infrastructure is now in place. SCHURTER (an equity-aligned white-label partner), Würth, Farnell, RS, Waldom and DigiKey give a micro-cap the reach of a much larger supplier. Design-wins with a global semiconductor company and a multinational conglomerate suggest qualification credibility.
-
Operating leverage plus margin repair. Gross margin was ~43–45% under a better mix in FY21–FY23. Repatriating Nation Gate production, the clean coating room and higher utilisation could restore margins toward the high-30s. At A$8–10m revenue, the R&D refund-supported cost base (opex excluding legal now about A$7m) could approach EBITDA breakeven.
Bear case
-
Chronic cash consumption and dilution. Underlying H1 FY26 operating outflow was about A$2.7m. The ~£2.3m raised is mostly committed to capex. A further raise within 12 months is likely, at a share price already down about 99% over five years. The share count has risen 2.6x in about two years.
-
Margin and scale problem may be structural. Gross margin fell to 29.1% in H1 FY26 even as revenue grew. Former licensees (AVX, TDK) and large incumbents compete. At about 1.5–2% of a ~US$200m prismatic niche, CAP-XX lacks the pricing power and procurement scale to earn adequate returns.
-
Credibility and governance flags. Several factors raise execution risk:
-
The FY22 promise of positive EBITDA was missed.
-
The calendar-2026 breakeven aspiration was missed.
-
FY24 was restated and the auditor changed.
-
Two interim CFOs served in 2025.
-
The 2026 placing RNS contains apparent errors (the 11% vs 6.1% revenue growth claim; director percentages showing 48.68% vs 9.79%).
-
Core patents were invalidated.
-
Key catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Expected timing | What to watch |
|---|---|---|
| FY26 audited results and annual report | By 31 Dec 2026 (FY25 precedent: early Nov) | Confirmation of A$5.24m revenue and the growth basis; gross margin; cash at 30 Jun 2026; going-concern language; geographic split; remuneration |
| 2026 AGM | ~Nov–Dec 2026 | Share authorities (signal of further raises); board independence |
| FY26 R&D tax refund | H1 FY27 (Dec precedent) | Amount (~A$1.5–2m indicative based on history) |
| Capex execution | FY27 | DMF/DMT upgrade completion; DMH ramp to full production; clean room commissioning; Nation Gate transition without customer loss |
| H1 FY27 trading update and interims | ~Jan–Feb 2027 | Revenue conversion of backlog; book-to-bill; margin trajectory |
| Partner traction | Ongoing | SCHURTER project wins; Würth and distributor design-in volumes |
| Permanent CFO appointment | Unspecified | Finance-function stability |
| Product launches | FY27 | SMT reflow-capable supercaps; Module range first orders (grid / data centre) |
| Further equity issuance | Likely within 12 months (analyst view) | Pricing and discount; insider participation |
Concluding analyst verdict
CAP-XX is a technically credible but financially fragile niche manufacturer. It now has its best commercial infrastructure in two decades and its weakest financial headroom.
What has improved. The 2023–2026 transformation under CEO Lars Stegmann and Chairman Graham Cooley has produced tangible operational gains:
-
Integrated ERP, WMS and CRM systems.
-
Better yields at Seven Hills.
-
Working-capital days roughly halved in FY25.
-
An enviable distribution roster for a company of its size, anchored by SCHURTER as both white-label partner and ~5% shareholder.
FY26 bookings growth of nearly 35% and a book-to-bill of about 1.3 are the most encouraging data points since the ex-Murata lines were commissioned in 2020.
What has not. The financial model is still unproven:
-
Revenue has compounded at only about 5% a year since FY21.
-
Gross margin has structurally reset to ~30% from the mid-40s.
-
Operating cash burn before the R&D refund runs at about A$5m+ a year against a ~A$18m market capitalisation.
-
The company has no financial debt but depends on discounted equity raises and Australian R&D refunds. Each raise compounds dilution: shares in issue have risen ~2.6x in two years.
The 2026 placing is a bet that capacity, not demand, is the binding constraint. That claim is plausible given flat H2 revenue against a rising backlog, but it remains unproven.
Governance. Signals are mixed. Insider alignment is high: directors hold ~11% and convert fees to equity. But finance-function turnover, a restatement, an auditor change and arithmetic inconsistencies in the most recent fundraising announcement warrant caution.
Verdict: Speculative / high risk — monitor for evidence of margin recovery. The equity is effectively an option on capacity-led revenue acceleration in FY27. The decisive evidence will come from:
-
FY26 audited accounts: cash position and the basis of the growth claim.
-
Whether H1 FY27 revenue moves materially above the ~A$2.6m per half run-rate.
-
Whether gross margin recovers above ~35%.
Absent all three, further dilutive funding is likely before cash-flow breakeven, and the risk-reward stays unfavourable for all but highly risk-tolerant investors.
Source list (primary documents referenced)
-
CAP-XX RNS — Audited results for the year ended 30 June 2025 and Notice of AGM (7 Nov 2025)
-
CAP-XX RNS — Unaudited interim results for the period ended 31 Dec 2025 (2 Feb 2026)
-
CAP-XX RNS — Proposed Placing and Subscription to raise £2.0m and Retail Offer (30 Jul 2026)
-
CAP-XX RNS — Total Voting Rights (30 Sep 2026)
-
CAP-XX RNS — Management and board changes (7 Jan 2025)
-
CAP-XX RNS — Update on Patent Infringement (18 Dec 2023); Delaware judgment update (10 Jan 2024)
-
CAP-XX RNS — Trading Update (7 May 2024)
-
CAP-XX RNS — Interim Results H1 FY22 (23 Feb 2022) and H1 FY23 (28 Feb 2023); H1 FY23 Interim Report PDF
-
CAP-XX Annual Report 2009; CAP-XX corporate-development web page; CAP-XX FY23 results summary (IR page)
-
US Court of Appeals for the Federal Circuit, Order in No. 24-1411 (16 Feb 2024)
-
Alliance News / AJ Bell / Morningstar articles (2021–2026); Sharecast / Hargreaves Lansdown articles (2019–2026)
-
EEPower and eeNews Europe (Dec 2019, Murata line acquisition); SCHURTER press release (Nov 2024); Electronic Specifier (Nov 2024)
-
Mintz (Dec 2023, trial preview); Perivan (Aug 2026, fundraise)
-
Aggregators (flagged where used): StockAnalysis, Investing.com, Eulerpool, TradingView, Hargreaves Lansdown, Fidelity, London South East, TipRanks, Wikipedia
-
Market research (indicative only): IMARC Group, Market Data Forecast, Global Insight Services, Maximize Market Research, Global Info Research, QYResearch
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure (approx.) | Background | Shareholding post 3 Sep 2026 | % of 7,423,992,457 shares (analyst calc.) |
|---|---|---|---|---|---|
Dr Graham Cooley | Non-Executive Chairman (since Mar 2025; NED since Jun 2024) | ~2.3 years on board | Former CEO of ITM Power plc (hydrogen electrolysers). Clean-energy and technology-commercialisation track record. | 726,973,071 | 9.79% |
Lars Stegmann | Chief Executive Officer (executive director) | CEO since 2023 | Leads the distribution-led sales strategy. Prior roles and education not disclosed in materials reviewed. | 17,130,864 | 0.23% |
Patrick (Pat) Elliott | Non-Executive Director (former Chairman for more than a decade, until Mar 2025) |
| Long-serving chair through the licensing and Maxwell eras | 84,023,963 | 1.13% |
Peter Fraser | Non-Executive Director | Since ~2024 | Subscribed in 2024 placing (stake then 0.2%) | 15,757,566 | 0.21% |
Dr Anthony Sive | Non-Executive Director | Appointment date not disclosed in sources | Background not disclosed in sources | 0 | 0.00% |
Total | — | — | — | 843,885,464 | 11.37% |
Board & Management Changes
| Date | Change | Source |
|---|---|---|
May 2023 | Anthony Kongats (founder, CEO/Managing Director) exits | Wikipedia; H1 FY23 interim report |
Jun 2024 | Dr Graham Cooley appointed NED | Wikipedia |
13 Jan 2025 | Steen Feldskov (NED, ~3 years, electronic-component distribution expert) steps down at the AGM | RNS, 7 Jan 2025 |
19 Mar 2025 | Board restructured: Cooley becomes Chairman; Elliott continues as NED; share options granted | RNS, 19 Mar 2025; FY25 Chairman's Statement |
Executive Leadership Team
| Name | Role | Date | Background | Source |
|---|---|---|---|---|
Lars Stegmann | CEO | 2023–present | See board table | — |
Dr Alex Bilyk | Chief Technology Officer | — | Long-standing CAP-XX technologist (secondary source) | Wikipedia |
Ariel Sivikofsky | Interim CFO (non-board) | Appointed 7 Jan 2025 for an initial six months |
| RNS, 7 Jan 2025 |
Anthony Guarna | Interim CFO | Appointed 9 Jun 2025; presented FY25 results in Nov 2025 | Described as bringing extensive financial leadership experience | RNS, 9 Jun 2025; FY25 results |
Previous CFO | Retired in 2024 (name not captured in sources) | 2024 | — | Sharecast headline "CAP-XX chief financial officer to retire" |
Company Secretary | Unnamed | — | Subscribing ~£10,000 in the 2026 raise | Placing RNS 2026 |
“—” = not publicly disclosed.
Major Shareholders
| Holder | Approx. stake | Source |
|---|---|---|
Dr Graham Cooley (Chairman) | ~9.79% | Placing RNS 2026; TVR 30 Sep 2026 |
SCHURTER AG (strategic partner) | ~5% | Placing RNS, 30 Jul 2026 |
Patrick Elliott | ~1.13% | As above |
Other directors | ~0.44% combined | As above |
Other notifiable holders | Multiple "Holding(s) in Company" RNSs: Jul, Aug, Sep (x2) and Oct 2025; Dec 2025; 4 Sep 2026. | LSE RNS index |
Competitive Landscape
Key Competitors
| Competitor | HQ | Relevant product focus | Positioning vs CAP-XX |
|---|---|---|---|
Eaton (Bussmann supercapacitors) | Ireland/US | Cylindrical, coin, small prismatic and modules | Massive channel reach and breadth. CAP-XX is thinner and has higher power density in prismatic. |
Kyocera AVX | US/Japan | SuperCapacitor modules, cells (a former CAP-XX licensee) | Licensee turned competitor; strong in medium/large formats |
TDK | Japan | Small prismatic EDLCs (former CAP-XX licensee) | Licensee; scale and customer access |
Murata | Japan | Exited supercapacitors (sold lines to CAP-XX in 2019) | Exit removed a competitor and gave CAP-XX its product base |
Panasonic | Japan | Gold Capacitor (coin/cylindrical EDLC) | Coin-format incumbent in back-up power |
Nippon Chemi-Con | Japan | DLCAP cylindrical EDLCs | Cylindrical, automotive and industrial |
Taiyo Yuden / Elna | Japan | EDLCs and lithium-ion capacitors | Hybrid LIC alternative |
KEMET (Yageo) | US/Taiwan | Supercapacitors (coin and cylindrical) | Broad passives catalogue |
Musashi Energy Solutions | Japan | Lithium-ion capacitors | Higher-energy hybrid cells |
Skeleton Technologies | Estonia/Germany | Curved-graphene ultracapacitors and modules (transport, grid) | Large-format modules; overlaps with CAP-XX's Module ambitions |
LS Materials | South Korea | Ultracapacitor cells and modules | Large-format industrial and wind pitch |
Vinatech | South Korea | EDLCs, small to large | Cost-competitive Asian supplier |
UCAP Power (former Maxwell ultracapacitor business) | US | Large-format ultracapacitors | Legacy Maxwell product line; past litigation counterparty |
Seiko Instruments | Japan | Thin chip EDLCs for wearables | Direct overlap in ultra-thin wearables |
Peer Comparison FY2025
| Metric | CAP-XX (FY25) | Eaton | Kyocera AVX | TDK |
|---|---|---|---|---|
Supercap-related revenue | A$4.94m (100% of group) | — | — | — |
Revenue growth | +7.5% | Not disclosed (segment) | Not disclosed (segment) | Not disclosed (segment) |
Gross margin | 29.7% | Not disclosed (segment) | Not disclosed (segment) | Not disclosed (segment) |
R&D intensity | 25.8% of revenue (research line only) | Group-level only | Group-level only | Group-level only |
Form-factor focus | Thin prismatic, 0.4–2.2 mm | Broad | Broad / modules | Small prismatic |
Manufacturing scale | Single main plant (Sydney) plus Asian partners | Global | Global | Global |
“—” = not publicly disclosed.
Recent Developments
Not found in the review period: * layoffs, litigation, regulatory actions or guidance revisions (beyond the implicit lapse of the calendar-2026 breakeven aspiration). As of 9 Oct 2026, no FY26 audited results had been announced. TradingView had listed an expected date of 24 Sep 2026. FY25 results were released on 7 Nov 2025, and the AIM deadline for FY26 is 31 Dec 2026.



